APA (7th ed.) Citation

Z, C., F, Y., Z, J., L, S., L, W., Z, H., . . . S, L. (2026). Plain language summary: Comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study. Future oncology (London, England), 22(14), 1637. https://doi.org/10.1080/14796694.2026.2676052

Chicago Style (17th ed.) Citation

Z, Chen, et al. "Plain Language Summary: Comparing Ivonescimab Plus Chemotherapy with Tislelizumab Plus Chemotherapy in People with Advanced Squamous Non-small Cell Lung Cancer in the HARMONi-6 Study." Future Oncology (London, England) 22, no. 14 (2026): 1637. https://doi.org/10.1080/14796694.2026.2676052.

MLA (9th ed.) Citation

Z, Chen, et al. "Plain Language Summary: Comparing Ivonescimab Plus Chemotherapy with Tislelizumab Plus Chemotherapy in People with Advanced Squamous Non-small Cell Lung Cancer in the HARMONi-6 Study." Future Oncology (London, England), vol. 22, no. 14, 2026, p. 1637, https://doi.org/10.1080/14796694.2026.2676052.